Article Cited by others

ORIGINAL ARTICLE

Indirect comparison between abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer: a systematic review

Zhang Wei, Wu Teng-Yun, Chen Qi, Shi Xiao-Lei, Xiao Guang-An, Zhao Lin, Xu Chuan-Liang, Zhou Tie, Sun Ying-Hao

Year : 2017| Volume: 19| Issue : 2 | Page no: 196-202

   This article has been cited by
 
1 Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review
Yash B. Shah, Amy L. Shaver, Jacob Beiriger, Sagar Mehta, Nikita Nikita, William Kevin Kelly, Stephen J. Freedland, Grace Lu-Yao
Cancers. 2022; 14(15): 3773
[Pubmed]  [Google Scholar] [DOI]
2 Identification of Key microRNAs in Diabetes Mellitus Erectile Dysfunction Rats with Stem Cell Therapy by Bioinformatic Analysis of Deep Sequencing Data
Jiaqi Kang, Yuxuan Song, Zhexin Zhang, Shangren Wang, Yi Lu, Xiaoqiang Liu
The World Journal of Men's Health. 2022; 40
[Pubmed]  [Google Scholar] [DOI]
3 Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer
Carlo Cattrini,Rodrigo Espańa,Alessia Mennitto,Melissa Bersanelli,Elena Castro,David Olmos,David Lorente,Alessandra Gennari
Cancers. 2021; 13(18): 4522
[Pubmed]  [Google Scholar] [DOI]
4 Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer
Ciara S. McNevin,Anne-Marie Baird,Ray McDermott,Stephen P. Finn
Diagnostics. 2021; 11(2): 345
[Pubmed]  [Google Scholar] [DOI]
5 Efficacy and tolerability of current treatments for hormone-refractory prostate cancer patients with visceral metastases
Zeynep Oruç,M. Ali Kaplan,Mustafa Karaagaç,Neslihan Özyurt,Ali Murat Tatli,Ali Osman Kaya,Serkan Menekse,Engin Kut,Sinan Koca,Özlem Nuray Sever,Irem Yasin,Senar Ebinç,Esra Zeynelgil,Abdullah Sakin,Nazim Serdar Turhal,Abdurrahman Isikdogan
Future Oncology. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
Yi-Ting Lin,Yen-Chun Huang,Chih-Kuan Liu,Tian-Shyug Lee,Mingchih Chen,Yu-Ning Chien
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
7 MiR-182-5p, MiR-192-5p, and MiR-493-5p Constitute a Regulatory Network with CRISP3 in Seminal Plasma Fluid of Teratozoospermia Patients
Delnya Gholami,Farzane Amirmahani,Reza Salman Yazdi,Tahereh Hasheminia,Hossein Teimori
Reproductive Sciences. 2021;
[Pubmed]  [Google Scholar] [DOI]
8 Abiraterone acetate plus Prednisone/Prednisolone compared with Enzalutamide in metastatic castration resistant prostate cancer before or after chemotherapy: A retrospective study of real-world data (ACES)
Prantik Das,Sarah Taylor,James Price,Michael Jones,Cristina Martin-Fernandez,Akram Ali,Thangrarajh Mugunthan,Chandrani Mallik,Colin Ward
BJUI Compass. 2020; 1(1): 21
[Pubmed]  [Google Scholar] [DOI]
9 Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer
Tie Zhou,Weidong Xu,Wei Zhang,Ye Sun,Honghua Yan,Xu Gao,Fubo Wang,Qianxiang Zhou,Jianguo Hou,Shancheng Ren,Qing Yang,Bo Yang,Chuanliang Xu,Qingqing Zhou,Meiyu Wang,Chunyun Chen,Yinghao Sun
European Journal of Cancer. 2020; 134: 29
[Pubmed]  [Google Scholar] [DOI]
10 Pharmacotherapeutic strategies for castrate-resistant prostate cancer
Mohamad Moussa,Athanasios Papatsoris,Mohamed Abou Chakra,Despoina Sryropoulou,Athanasios Dellis
Expert Opinion on Pharmacotherapy. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
11 Overall Survival Among Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer Under Abiraterone Versus Enzalutamide: A Direct Comparison Based on a 2014–2018 French Population Study (the SPEAR Cohort)
Lucie-Marie Scailteux,Boris Campillo-Gimenez,Sandrine Kerbrat,Fabien Despas,Romain Mathieu,Sébastien Vincendeau,Frédéric Balusson,André Happe,Emmanuel Nowak,Emmanuel Oger
American Journal of Epidemiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
12 Encapsulated three-dimensional bioprinted structure seeded with urothelial cells
Yi-Peng Jin,Chong Shi,Yuan-Yi Wu,Ji-Lei Sun,Jiang-Ping Gao,Yong Yang
Chinese Medical Journal. 2020; 133(4): 424
[Pubmed]  [Google Scholar] [DOI]
13 A systems biology framework integrating GWAS and RNA-seq to shed light on the molecular basis of sperm quality in swine
Marta Gňdia,Antonio Reverter,Rayner González-Prendes,Yuliaxis Ramayo-Caldas,Anna Castelló,Joan-Enric Rodríguez-Gil,Armand Sánchez,Alex Clop
Genetics Selection Evolution. 2020; 52(1)
[Pubmed]  [Google Scholar] [DOI]
14 Harnessing Stem Cell Potential for the Treatment of Erectile Function in Men with Diabetes Mellitus: From Preclinical/Clinical Perspectives to Penile Tissue Engineering
Serap Gur,Wayne J.G. Hellstrom
Current Stem Cell Research & Therapy. 2020; 15(4): 308
[Pubmed]  [Google Scholar] [DOI]
15 Efficacy and safety of abiraterone and enzalutamide for castration-resistant prostate cancer
Xiaonan Zheng,Xiaohui Zhao,Hang Xu,Xin Han,He Xu,Xin Dong,Ruilin Peng,Lu Yang,Qiang Wei,Jianzhong Ai
Medicine. 2019; 98(44): e17748
[Pubmed]  [Google Scholar] [DOI]
16 Mesenchymal stem cell therapy improves erectile dysfunction in experimental spinal cord injury
Ömercan Albayrak,Tarik Emre Sener,Mehmet Ersahin,Suna Özbas-Turan,Ceyda Ekentok,Hasan Hüseyin Tavukçu,Özge Çevik,Sule Çetinel,Büsra Ertas,Göksel Sener
International Journal of Impotence Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
17 Comparison of Oncologic Outcomes between Two Alternative Sequences with Abiraterone Acetate and Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
Doo Yong Chung,Dong Hyuk Kang,Jong Won Kim,Do Kyung Kim,Joo Yong Lee,Chang Hee Hong,Kang Su Cho
Cancers. 2019; 12(1): 8
[Pubmed]  [Google Scholar] [DOI]
18 The Treatment of Metastatic and Castration-Resistant Prostate Cancer Patients in Korea
Yoon Soo Hah,U-Syn Ha,Jin-Woo Jung,Bong Hee Park,Hyung Joon Kim,Ki Hong Kim,Jeong Kyun Yeo
The Korean Journal of Urological Oncology. 2019; 17(1): 48
[Pubmed]  [Google Scholar] [DOI]
19 Effectiveness and tolerability of targeted drugs for the treatment of metastatic castration-resistant prostate cancer: a network meta-analysis of randomized controlled trials
Yongquan Wang,Heng Zhang,Wenhao Shen,Peng He,Zhansong Zhou
Journal of Cancer Research and Clinical Oncology. 2018;
[Pubmed]  [Google Scholar] [DOI]
20 Survival Outcomes, Prostate-Specific Antigen (PSA) Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-Resistant Prostate Cancer (mCRPC): a Real-World Experience in Hong Kong
Darren M.C. Poon,Kenneth C.W. Wong,T.W. Chan,Kitty Law,Kuen Chan,Eric K.C. Lee,Conrad Lee,Michelle Chan
Clinical Genitourinary Cancer. 2018;
[Pubmed]  [Google Scholar] [DOI]
21 Treatment of hormone-naďve metastatic prostate cancer
Zineb Hamilou,Fred Saad,Karim Fizazi
Current Opinion in Supportive and Palliative Care. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
22 Current therapeutic options in metastatic castration-resistant prostate cancer
Gianluca Ingrosso,Beatrice Detti,Daniele Scartoni,Andrea Lancia,Irene Giacomelli,Muhammed Baki,Giulio Carta,Lorenzo Livi,Riccardo Santoni
Seminars in Oncology. 2018; 45(5-6): 303
[Pubmed]  [Google Scholar] [DOI]
23 SEQUENTIAL THERAPY OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: NEW POSSIBILITIES
A. S. Markova,V. B. Matveev,B. M. Nazranov
Cancer Urology. 2018; 14(3): 120
[Pubmed]  [Google Scholar] [DOI]
24 Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison
Haofeng Zheng,Jialiang Chen,Wenhan Qiu,Sijie Lin,Yanxiong Chen,Guancan Liang,Youqiang Fang
BioMed Research International. 2017; 2017: 1
[Pubmed]  [Google Scholar] [DOI]
25 Isoflurane inhalation anesthesia should be a new requirement in intracavernosal pressure detection—the gold standard of erectile function assessment
Jinhong Li,Changjing Wu,Fudong Fu,Xuanhe You,Liang Gao,Romel Wazir,Feng Qin,Ping Han,Jiuhong Yuan
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
26 Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologistsć perspective
Jo-Lynn Tan,Niranjan Sathianathen,Nicolas Geurts,Rajesh Nair,Declan G. Murphy,Alastair D. Lamb
Urological Science. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article